Bioequivalence Study of INS062 and Pharmacokinetics and Pharmacokinetics Study of Single Injection of HR20014 in Healthy Subjects

NCT05719961 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes

Interventions

DRUG: INS062 injection
DRUG: Insulin Aspart
DRUG: HR20014 injection
DRUG: Insulin Aspart 30 Injection

Sponsor

Jiangsu HengRui Medicine Co., Ltd.